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http://www.biomedcentral.com/1471-2393/13/236RESEARCH ARTICLE Open AccessA structured review and exploration of the
healthcare costs associated with stillbirth and a
subsequent pregnancy in England and Wales
Hema Mistry1, Alexander E P Heazell2, Oluwaseyi Vincent3 and Tracy Roberts1*Abstract
Background: In contrast to other pregnancy complications the economic impact of stillbirth is poorly understood.
We aimed to carry out a preliminary exploration of the healthcare costs of stillbirth from the time of pregnancy loss
and the period afterwards; also to explore and include the impact of a previous stillbirth on the healthcare costs of
the next pregnancy.
Methods: A structured review of the literature including cost studies and description of costs to health-care providers
for care provided at the time of stillbirth and in a subsequent pregnancy. Costs in a subsequent pregnancy were
compared in three alternative models of care for multiparous women developed from national guidelines and
expert opinion: i) “low risk” women who had a live birth, ii) “high risk” women who had a live birth and iii) women
with a previous stillbirth.
Results: The costs to the National Health Service (NHS) for investigation immediately following stillbirth ranged
from £1,242 (core recommended investigations) to £1,804 (comprehensive investigation). The costs in the next
pregnancy following a stillbirth ranged from £2,147 (low-risk woman with a previous healthy child) to £3,751
(Woman with a previous stillbirth of unknown cause). The cost in the next pregnancy following a stillbirth due to
a known recurrent or an unknown cause is almost £500 greater than the pregnancy following a stillbirth due to a
known non-recurrent cause.
Conclusions: The study has highlighted the paucity of evidence regarding economic issues surrounding stillbirth.
Women who have experienced a previous stillbirth are likely to utilise more health care services in their next
pregnancy particularly where no cause is found. Every effort should be made to determine the cause of stillbirth
to reduce the overall cost to the NHS. The cost associated with identifying the cause of stillbirth could offset the
costs of care in the next pregnancy. Future research should concentrate on robust studies looking into the wider
economic impact of stillbirth.
Keywords: Costs and cost analysis, Stillbirth, Multiparous women, NHSBackground
In the UK, stillbirth is defined as “a baby delivered with
no signs of life, known to have died at 24 completed
weeks of pregnancy onwards” [1]. In 2012, there were
3,558 stillbirths in England and Wales, a rate of 4.9 per
1,000 total births [2]. Despite advances in obstetric care,
the incidence of stillbirth is not significantly lower than* Correspondence: t.e.roberts@bham.ac.uk
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reproduction in any medium, provided the or25 years ago (1987: 3,423 stillbirths, a rate of 5.0 per
1,000 total births). Of concern is the UK stillbirth rate
which ranks 33rd out 35 high-income countries [2,3]. In
contrast to other pregnancy complications such as preterm
birth and preeclampsia [4-6], the economic impact of
stillbirth is poorly understood. This is problematic for
two reasons; first it underestimates the societal impact of
stillbirth in comparison to other pregnancy complications.
Second, it represents a major obstacle in the evaluation
of strategies to reduce stillbirth, as investigators cannottd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in costs associated with stillbirth. Recently, several reports
have discussed issues related to health economics of
stillbirth [7-9].
Potential economic costs associated with stillbirth
may be grouped temporally, into i) those which occur
at the time of initial management of the stillbirth, ii)
those which are incurred after the initial management
has been completed and iii) those which occur specific-
ally in a subsequent pregnancy. Clinical guidance from
the Royal College of Obstetricians and Gynaecologists
(RCOG) recommends that pregnancy after stillbirth is
managed as high-risk [10], this is due to the significantly
elevated risk of a stillbirth in a subsequent pregnancy
[11]. However, this does not apply to all causes of still-
births, some of which result from non-recurrent events
such as viral infection, isolated structural fetal anomaly
or umbilical cord accident [12]. Stillbirths, associated
with placental complications such as abruption and
fetal growth restriction (FGR) are associated with a two
to ten-fold higher recurrence risk of stillbirth in the
next pregnancy [13]. In a recent study of 163 women,
11 (6.7%) had a subsequent stillbirth, of which at least
6 (54%) had similar pathologies in both events [14]. To
address the increased risk of recurrent stillbirth, serial
ultrasound scans are recommended in the next preg-
nancy to identify FGR and to provide reassurance to
women and their partners [15]. In addition, due to
increased maternal anxiety in a subsequent pregnancy
some women will seek more frequent but unnecessary
antenatal visits and testing, usually by ultrasound scan-
ning, assuming, perhaps mistakenly, that they have a
higher than average risk of recurrence, while other
women who truly are ‘high risk’ are the ones who
should be offered the extra visits and testing [16]. A
better understanding of the costs to society and the
health care sector, associated with stillbirth from the
time of loss onwards would allow those responsible
for care provision to appreciate the breadth of the
impact of stillbirth and ensure that resources are used
as efficiently as possible. Given the enormity of
assessing the potential impacts of stillbirth we have
deliberately restricted this initial assessment to the
perspective of the health care provider. Therefore, we
aimed to i) Review published literature to identify
studies of the economic impact of stillbirth, ii) calcu-
late the economic costs of care at the time of stillbirth
including investigation of the cause, iii) calculate the
economic costs of care in a subsequent pregnancy
after stillbirth and compare this to women who have
had a live birth and iv) consider the trade-off that ex-
ists between the cost of investigations to determine
the cause of stillbirth and the potential saving of add-
itional investigations in the next pregnancy.Methods
Structured review - search strategy
A structured approach to reviewing the economic lit-
erature was undertaken using established methods [17].
Typically because of the heterogeneity of the relevant
economic literature, unlike clinical trials, such reviews rely
on a qualitative critique of the relevant studies as opposed
to a meta-analysis. The following databases were searched:
MEDLINE, EMBASE, CINAHL, Science Citation Index
(SCI) and Social Science Citation Index (SSCI) by OV.
In addition, reference lists of retrieved studies were also
scanned. Publications relating to the cost of stillbirth
were identified by combining the stillbirth terms with
the economic terms an example of a search strategy is
shown below.
1. stillbirth/
2. stillbirth$.mp.
3. fetal death/
4. perinatal loss.mp.
5. pregnancy loss.mp.
6. perinatal death.mp.
7. or/1-6
8. exp “costs and cost analysis”/
9. exp health care costs/
10. economics/
11. budget$.tw.
12. or/8-11
13. 7 and 12
14. limit 13 to (english language and humans)
15. limit 14 to last 10 years
Studies which described resource use and costs (in mon-
etary terms) associated with stillbirth were included.
Studies were excluded if it was not possible to differenti-
ate between stillbirths and other forms of pregnancy loss
or child death e.g. first trimester miscarriage or if re-
source use was not quantified. Searching was restricted
to articles published in English language and to humans,
between January 1998 to October 2013.
A two-stage screening process was used to select pa-
pers for the review [17]. Using this strategy papers iden-
tified using the search strategy were initially categorised
by one author (OV) based on titles and abstracts: A) the
study reports primary or secondary research on estimat-
ing the resource use or costs associated with stillbirth; B)
the study reports resource use in care pathways for women
who have experienced a stillbirth; C) the study may prove
to have useful information but does not fall into (A) or (B);
or D) the study does not have any relevance. Any studies in
(A), (B) and (C) were considered potentially relevant to
this structured review. Final categorization of studies
was based on reading of the full papers by two authors
(OV and HM) in groups (A), (B) and (C), identified
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relevant cost and resource use data was then extracted
from papers included in the review. Cost data in local cur-
rencies was inflated to 2010 prices using the Gross Domes-
tic Product deflators [18] and then converted to UK
£ sterling 2010 using purchasing power parities [19].
Identification of care pathways for women immediately
following a stillbirth
We explored UK guidelines from the RCOG to establish
the full range of investigations that are likely to be
offered to women immediately after they experience a
stillbirth [10]. We compiled a list of tests, interventions
and procedures based on these guidelines and used
data from local perinatal audit [20] to confirm the most
likely package of care for women in the UK. Care was
grouped according to the RCOG guideline into items
recommended for the majority cases of stillbirth (autopsy/
post-mortem, placental pathology, Kleihaur test, bereave-
ment counselling) and those recommended dependent
upon the clinical presentation (biochemical, haemato-
logical, immunological and microbiological tests).
Determining care pathways and patient numbers for
pregnancy following a stillbirth
We developed care pathways for women experiencing
pregnancy after stillbirth using published guidance from
the RCOG, National Institute of Health and Clinical
Excellence (NICE) and expert opinion (Keelin O’Donoghue,
Cork, Ireland; Alexander Heazell, Manchester, UK) [10,21].
For comparison we also developed care pathways for
two other cohorts of pregnant multiparous women with
singleton pregnancies, i) healthy women who had an
uncomplicated first pregnancy ending in a live-birth
and ii) women with designated “high-risk pregnancies”
due to pre-existing conditions, for example, diabetes or
hypertension whose first pregnancy ended in a live
birth. Pre-existing diabetes and hypertension were chosen
to represent “high-risk pregnancies” because they are the
most frequently encountered maternal medical disorders
in clinical practice that confer a high risk status and there
are published guidelines for their management during
pregnancy [22,23]. To address whether determination
of the cause of stillbirth altered the costs of care in a
subsequent pregnancy, the group of women with previous
stillbirth were further divided into three groups: (i) a
known non-recurrent cause; (ii) those with a known
recurrent cause; and (iii) those with an unknown cause.
Therefore, we defined six groups of women overall,
who were differentiated by whether or not the previous
pregnancy resulted in a live birth or a stillbirth; whether
the women had diabetes or hypertension (examples of
‘high-risk’ pregnancies); and whether or not the causes
of the stillbirth was known. Group 1 - Healthy multiparous women who had an
uncomplicated pregnancy (‘normal’ women) [21]
 Group 2 - High-risk multiparous women with a
previous healthy child
○ Group 2a - ‘Diabetic’ women [23]
○ Group 2b - ‘Hypertensive’ women [22]
 Group 3 - Multiparous women with a previous
stillbirth
○ Group 3a - Women with known non-recurrent
causes (e.g. parvovirus, isolated structural fetal
anomaly, umbilical cord accident which are
unlikely to recur in a subsequent pregnancy)
○ Group 3b - Women with known recurrent
causes (e.g. fetal growth restriction which are
known to recur in subsequent pregnancies)
○ Group 3c - Women with unknown causes
Using data from published guidelines and expert opinion
(as above), the number of antenatal visits and ultrasound
scans were estimated for each of the different care
pathways. For all groups (except group 1), pre-conception
care was also included, which included at least one GP
visit and one visit to a physician. For those women who
had a stillbirth in a previous pregnancy, 80% of women
had a term delivery of their next pregnancy (37–40 weeks
gestation) and the remaining 20% were preterm (<37 weeks
gestation) [24]. The preterm birth rate was assumed to
be between 8 and 10% for women who had a previous
healthy child [25].
With the exception of the costs of bereavement coun-
selling, the costs for investigations following a stillbirth
were obtained by one author (AH) who leads a specialist
clinical service for parents following stillbirth. Unit costs
for antenatal care and delivery care were obtained from
NHS reference costs [26] and staff time was estimated
from published salary scales [27] (see Table 1). Having
established the number of antenatal visits (including
ultrasound scans) and the mode of delivery for each
care pathway, a mean total cost per patient for each
care pathway was generated using average unit costs.
All unit costs are presented in £ sterling 2010 prices
and a NHS perspective was adopted. Costs incurred in
the next pregnancy were not discounted because it was
assumed that conception occurred within a year of the
stillbirth [28]. We estimated average cost for each preg-
nancy pathway and a best scenario (using lower quartile
costs) and a worst scenario (using upper quartile costs).
Results
Structured literature review
Overview of the results
Six hundred and fifty one papers were identified in the
literature search after removing duplicates. No further
papers were identified through the references of retrieved
Table 1 Unit costs in 2010 prices
Resource use Unit costs in £s in 2009/2010 prices Source
Average Lower quartile Upper quartile
Pre-conception care
GP visit (clinic consultation lasting 17.2 minutes) £53 n/a n/a 22
Physician visit (consultation lasting 25 minutes) £45 n/a n/a 22
Consultant led multiprofessional consultation (first attendance) £179 £153 £205 21
Consultant led multiprofessional consultation (follow-up attendance) £134 £111 £140 21
Antenatal care
Midwife appointment (lasting 20 minutes) £23 n/a n/a 22
Antenatal attendances
Consultant led consultant consultation (first attendance) £150 398 £183 21
Consultant led consultant consultation (follow-up attendance) £96 £62 £114 21
Consultant led consultant multiprofessional consultation (follow-up attendance) £134 £111 £140 21
Consultant led midwife consultation (first attendance) £77 £51 £86 21
Consultant led midwife consultation (follow-up attendance) £51 £32 £58 21
Consultant led midwife multiprofessional consultation (first attendance) £72 £72 £72 21
Consultant led midwife multiprofessional consultation (follow-up attendance) £51 £51 £51 21
Outpatient procedure: antenatal investigation £127 £88 £151 21
Antenatal ultrasounds
Non-consultant led antenatal ultrasound (first attendance) £63 £45 £87 21
Non-consultant led antenatal ultrasound (follow-up attendance) £52 £40 £58 21
Delivery care (Elective episodes)
Normal delivery with CC £1,558 £893 £2,037 21
Normal delivery without CC £1,151 £433 £1,644* 21
Assisted delivery without CC £1,374 £1,167 £1,872* 21
Planned lower uterine caesarean section £1,822 £1,276 £1,985 21
Emergency or upper uterine caesarean section £2,979 £2,915 £3,463 21
*The upper quartile cost was lower than the mean cost for both cases, therefore the mean cost for non-elective was used. The costs for the previous financial year
were not in line with these costs.
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of the authors (AH); this paper was not available via any
of the databases which were searched. Following review
of the titles and abstracts of identified papers, it was
clear that none of the studies reported information on the
overall resource use or cost associated with stillbirth
defined as group (A), or on the care pathways for women
after a stillbirth defined as group (B). Only five papers
were considered to include potentially relevant data and
referred to as Group (C), and these were retrieved and the
full manuscript reviewed. Three of these studies were
considered to report information useful to the review. The
other two studies were excluded: one was an abstract
summary of one the included papers (Michalski et al.,
2002) [29,30]; and the other study did not report frequency
or numbers for resource use information [16]. All three
studies reported information on direct costs associated
with stillbirth. Two studies looked at cost of management
after a stillbirth, specifically diagnostic investigations[29,31] and the other study focussed on the damages
paid on stillbirth claims [30].
Further details of the relevant studies
Michalski et al. conducted a cost-consequences analysis
of comprehensive stillbirth (defined as fetal death after
20 weeks gestation) assessment [29]. Data on 1,477 stillborn
pregnancies were obtained from the Wisconsin Stillbirth
Service Program (WiSSP). A step-by-step costing process
was carried for the stillbirth assessment, using estimates
of local salaries (measures of time and wage) and material
costs data. The authors estimate of the total cost of still-
birth assessment was approximately $1,450 (reported in
2002 prices), which included the cost of pathologic
evaluation, cytogenetic evaluation, photographs and radio-
graphs and other evaluations, diagnostic interpretation
and counselling, plus overhead costs (estimate 45.5%)
were added. Gold et al. conducted a review of patient
records between 1996 and 2006 of 533 stillbirths matched
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They calculated healthcare cost including labour, birth
and any fetal testing or monitoring. The mean hospital
cost for a stillbirth was $7,495 (Range: $659-$77,080)
compared to $6,600 for live births (Range: $269-$64,010).
Using a logistic-regression model, Gold et al. demon-
strated that costs for stillbirth were greater than live
births even when multiple births and serious medical
complications were excluded. Mead reported information
on the NHS costs of litigation and damages paid out on
a 100 stillbirth claims filed between 2003 and 2007
[32]. A total of £1,761,638 was paid in damages for 62
cases, averaging £28,413 per successful claim.Costs of investigation and care following a stillbirth
Table 2 presents a summary of the key components for
comprehensive care at the time of stillbirth; thus these
are the costs of ideal care offered to parents following a
stillbirth. For each woman an initial counselling session
with the midwife and eight additional sessions of coun-
selling with a specialist bereavement counsellor were
assumed based on data from published sources [33,34].
We also include the cost of the post-mortem examination
(this is the most costly component at £650) and the core
investigations which would total £1,242. If the women
had other investigations depending on the clinical scenario
this could add anything from £6 to £562 to the total cost
of stillbirth care. This suggests that the cost per pregnancy
immediately following a stillbirth could be as high as
£1,804. We found no evidence to quantify the costs in the
time period between completion of the care recommended
following a stillbirth and the initiation of care for a sub-
sequent pregnancy, or to help estimate the costs which
are incurred during this period.Antenatal and delivery care costs in a
subsequent pregnancy
Table 3 shows the frequency of antenatal attendances
and ultrasound scans for each of the care pathways and
Table 4 shows the probable modes of delivery for each
care pathway based upon data from perinatal audit and
population-based studies of mode of delivery [35-37].
The costs for subsequent pregnancy in the individual
groups are shown in Tables 3 and 5. For those women
who delivered to full term, the cost of antenatal care
ranged from £724 (Group 1 – Healthy multiparous women
who had an uncomplicated pregnancy) to £2,002 (Group
3c – Women with a previous stillbirth with an unknown
cause), where group 1 had 9 antenatal visits and 2 ultra-
sound scans compared with group 3c who had 15 antenatal
visits and 5 ultrasound scans. Antenatal care costs in the
next pregnancy, for a woman who had a stillbirth due to
either known recurrent or unknown cause are calculatedto be almost £500 more costly than for a woman who
experienced a stillbirth due to known non-recurrent cause.
In the absence of data to the contrary, we have assumed
that for women who had experienced a stillbirth, the
probabilities for the different modes of delivery would
not differ for each of the different care pathways. When
delivery costs where included, the total costs of care
ranged from £2,147 (Group 1) to £3,870 (Group 2 – “High
Risk” – Diabetic Multiparous Women). The cost of care
in a subsequent pregnancy for women with previous
stillbirth (£3,235-3,751) was comparable to other “high-risk”
pregnancies (£2,920-£3,870).
Table 5 includes a summary of the main results with
best and worst scenarios for costs presented on the basis
of interquartile ranges. The table shows the mean cost of
pregnancy to the NHS per pregnant multiparous woman
and the total cost of pregnancy to the NHS for all pregnant
women who followed each care pathway.
Discussion
Our structured review highlighted a dearth of evidence
associated with the economic impact of a stillbirth. We
initially aimed to holistically describe the economic
impact of stillbirth. However, following the structured
review it was clear there were insufficient data to address
this aim. Therefore, we have attempted here to quantify
the healthcare costs associated with stillbirth in three
time periods, i) those which occur at the time of initial
management of the stillbirth, ii) those which are incurred
after the initial management has been completed and iii)
those which occur specifically in a subsequent pregnancy.
Based on published UK guidelines, the estimated costs
to the NHS for period i) investigation and care following
a stillbirth ranged from £1,242 to £1,804. Given a post-
mortem rate of 40% [38], this implies the overall costs
of the care provided for women at the time of stillbirth
is almost £6 million per annum in England and Wales
(Table 5). It was not possible to estimate the costs to
the NHS or to women and their families after the initial
management of stillbirth had been completed until the
next pregnancy (period ii) because of a paucity of evidence
about the length of this period and events occurring
within this period. However, we have attempted to
quantify the costs of a subsequent pregnancy following
a stillbirth in a bottom-up manner [39]. The cost of
the care pathways and delivery ranged from £2,147 for
low-risk multiparous women with a previous healthy
child to £3,751 for a woman with a previous stillbirth of
unknown cause. We estimate that the cost of a second
pregnancy for otherwise healthy women with a previous
stillbirth with a known non-recurrent cause is £1,088
greater than that for a low-risk counterpart with a
previous live birth. Our preliminary analysis shows
that if the cause of stillbirth is unknown, the next
Table 2 Costs of comprehensive stillbirth care‡ (UK Sterling, price year 2010)
Resource type Cost Reference
Core investigations and counselling
Bereavement counselling* £521 [16,22]
Autopsy/post-mortem £650 University of Manchester Hospital Laboratory
Placental pathology £54 University of Manchester Hospital Laboratory
Kleihauer test £17 University of Manchester Hospital Laboratory
Total core investigations £1,242
Other investigations (depending on clinical scenarios)
Cytogenetics £246 University of Manchester Hospital Laboratory
Thrombophilia screen £132 University of Manchester Hospital Laboratory
- Prothrombin gene variant, Factor V Leiden mutation, Antithrombin III,
Protein C, Protein S, Lupus anticoagulant, anticardiolipin antibodies.
Pre-eclampsia £20 University of Manchester Hospital Laboratory
- Urea and electrolytes, liver function tests, serum urate.
HbA1c £6 University of Manchester Hospital Laboratory
Haematology £24 University of Manchester Hospital Laboratory
- Full blood count, DIC screen
Immunology £9 University of Manchester Hospital Laboratory
Biochemistry £28 University of Manchester Hospital Laboratory
- Bile acids, thyroid function tests, C-reactive protein.
Microbiology £55 University of Manchester Hospital Laboratory
- Blood cultures, mid-stream urine, vaginal swabs, cervical swabs.
Serology £42 University of Manchester Hospital Laboratory
- Parvovirus B19, rubella (if nonimmune at booking), CMV, herpes
simplex and Toxoplasma gondii
Total cost for all tests £1,804
*Initial session with midwife plus 8 sessions with a specialist bereavement counsellor.
‡ The resource use for comprehensive stillbirth care were obtained from RCOG guidelines on late intrauterine fetal death and stillbirth [10]. The guidelines recommend
that all women should be offered full post-mortem examination which would include an autopsy, x-rays and pathological examination of the cord and placenta. In
addition they suggest a list of diagnostic tests, these include the core tests recommended for all women, such as the Kleihauer test. Other investigations are
recommended based on the clinical scenario such as maternal haematology and biochemistry tests used to investigate pre-eclampsia and multi-organ failure.
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same as a ‘high-risk’ pregnancy such as the case of
pre-existing diabetes (Unknown stillbirth £3,720 vs.
Pre-existing diabetes £3,870).
If the cause of stillbirth is determined as non-recurrent,
this is likely to result in lower anxiety and stress to the
woman and her family and lower costs for the NHS. In
contrast, additional investigations such as more frequent
ultrasound scans, may be of greater benefit to women
with a previous stillbirth of known recurrent cause (e.g.
FGR), allowing limited resources to be prioritised to
those most likely to benefit from them [40]. Consequently,
performing investigations which at least exclude recurrent
conditions and reduce unexplained stillbirths may result
in a reduction in healthcare costs in a subsequent preg-
nancy. Since autopsy with placental histopathology is
most likely to provide information to reduce unexplained
stillbirths (changes primary diagnosis in 9-34%, confirms
diagnosis in 49-54%) these data provide additional impetusto increase the autopsy rate in the UK from the current
nadir of 40% to higher levels (~55%) prior to 2000 [41].
In addition to its physical consequences, stillbirth is a
profoundly traumatic experience for parents which poses
the risk of long-term negative effects on the family [42]
with the child’s siblings and grandparents also be emo-
tionally affected by stillbirth [43]. The potential adverse
emotional and psychological outcomes after a stillbirth
may impact upon employment and relationship breakdown
[44]. Considering the psychosocial consequences which
may result from a stillbirth in isolation, Cacciatore suggests
that the aggregate cost to society would be significant [45].
However, at present there is no quantifiable estimate
for these costs to add to our analysis. To fully describe
the economic implication of stillbirth, accurate estimates
of these adverse psychological and social outcomes of
stillbirth are required.
The main strength of this study is that it is the first
which has attempted to quantify the costs associated
Table 3 Frequency and total numbers of antenatal attendances, investigations and ultrasound scans*
Group Pre-conception
care costs
Total antenatal attendances Ultrasound scans Antenatal care Total care (including
antenatal and
delivery care)
Women who deliver
premature (<37
weeks gestation)
Women who
deliver to full
term (37 to 40
weeks gestation)
Women who deliver
premature (<37
weeks gestation)
Women who
deliver to full
term (37 to 40
weeks gestation)
Women who deliver
premature (<37
weeks gestation)
Women who
deliver to full
term (37 to 40
weeks gestation)
1: Women with a previous
healthy child
✗ 8 9 2 2 £673 £724 £2,147
2a: Women with a previous
healthy child but has diabetes
£500 11 13 5 5 £1,309 £1,411 £3,870
2b: Women with a
previous healthy child but
has hypertension
£188 10 12 5 5 £1,154 £1,256 £2,920
3a: Women with a previous
stillbirth – known causes
(non-recurrent)
£159 10 12 3 3 £1,294 £1,486 £3,235
3b: Women with a previous
stillbirth – known causes
(recurrent)#
£159 13 15 5 5 £1,779 £1,970 £3,720
3c: Women with a previous
stillbirth – unknown causes#
£159 13 15 5 5 £1,810 £2,002 £3,751
*Antenatal ultrasound scans are reported separately from antenatal appointments, as they are usually conducted in two different departments (even though they may be conducted during the same visit to the
hospital). #These data are estimates based on a study that investigated antenatal visits and scans which recorded a median of 10 (range 1 to 22) visits and 6 (range 1 to 22) ultrasound scans.
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Table 4 Probabilities for the different delivery modes for each care pathway
Group Normal without
complications
Normal with
complications
Assisted delivery Caesarean section
(emergency)
Caesarean section
(elective)
Source
1: Women with a previous healthy child 0.670 0.000 0.110 0.130 0.090 43
2a: Women with a previous healthy child
but has diabetes
0.244 0.005 0.077 0.376 0.298 43
2b: Women with a previous healthy child
but has hypertension
0.559 0.050 0.155 0.132 0.104 43-44
3: Women with a previous stillbirth 0.536 0.000 0.132 0.137 0.195 45
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structured literature review it has identified an import-
ant dearth in the current evidence and knowledge on
this issue. Currently the only evidence that exists that
can be used is available from reference costs and the
assumptions which have been explained. Using this
approach this study has highlighted crucial gaps in the
evidence, most notably of the economic impact of still-
birth above and beyond healthcare costs incurred in the
aftercare of a stillbirth and in any subsequent pregnancies.
The use of model care pathways was strengthened by
the use of NICE guidelines [21-23] and from two groups’
detailed review of care in subsequent pregnancies
(Manchester, UK and Cork, Ireland).
However, there are many limitations which are directly
related to the paucity of evidence and the lack of data.
For instance, the assumptions made that the next preg-
nancy post stillbirth would occur within a year and the
delivery would be normal. Anecdotal evidence suggests
reaching term and achieving a normal delivery are less
likely for this group of women and it is likely that a
high proportion of these women will be delivered early,
and by caesarean due to maternal anxiety and request. If
stillbirth prevention involves preterm delivery or operative
delivery, there would be further additional cost implica-
tions. Thus, the direct costs to the NHS estimated in
this study are, at best, conservative estimates and further
studies are needed to address specific gaps in the data
about subsequent pregnancy after stillbirth specifically:
the mode of delivery, frequency of induction of labour
or elective Caesarean birth, amount of additional antenatal
contact e.g. use of out of hours services. From an inter-
national perspectives, guidelines in other countries such
as Australia, New Zealand, and North America are
similar to the UK [46,47]. However, pathways would
have to be reanalysed in their own currencies and this
may have different cost implications.
Furthermore, due to lack of evidence we have not here
even attempted to calculate psychosocial costs of stress,
anxiety and counselling, or the societal impact of time
absent from work and employment costs. Compared to
parents who have a live birth, parents who experience
a stillbirth have a greater likelihood of relationship
breakdown [44,48], and are more likely to neglect theemotional needs of siblings [45]. Studies have described
significantly greater depression, anxiety and post-traumatic
stress disorder after stillbirth [49,50], which extends into
the subsequent pregnancy [51]. In addition, stillbirth also
has a substantial negative emotional effect on healthcare
professionals [52]. These wider costs are likely to impose
a significant economic burden on the health care sector
and society.
Conclusions
In summary, this study has highlighted the paucity of
evidence regarding the economic impact of stillbirth
and the paucity of guidelines for the management of
pregnancies following a stillbirth. Further research should
systematically quantify the care involved following a
stillbirth, in the next pregnancy and the time between
the two events and ongoing effects of stillbirth. Not-
withstanding the conservative nature of the financial
estimates presented in this paper, stillbirth places a
significant but unquantified financial burden on the
NHS. The current costs associated with antenatal care
in the next pregnancy (£15.1 million) combined with
litigation costs (approximately £1.6 million) [53] imposes
annual costs in the region of £16.7 million for the UK
health service. Costs of investigations to ascertain the
cause of stillbirth may contribute a significant part of this,
but could work to reduce the antenatal care costs for the
next pregnancy and for other women. Cost-effectiveness
requires by definition a comparison of both costs and
outcomes [39]. Clearly, the costs of this devastating
outcome to pregnancy are far more than just those that
can be estimated financially. In terms of effectiveness
or outcomes, currently applied estimates of the number
of quality adjusted life years (QALYs) for stillbirth are
set at 25 and only take into account the life of the fetus
(75 years discounted at 3.5% per year) [23]. Thus, the
impact on quality of life to women and their families as
a result of a stillbirth is so far un-quantified and un-
represented in cost-benefit analyses; further research is
necessary to appropriately value these outcomes. This
will allow the true economic impact of stillbirth to be
presented alongside estimates for other perinatal com-
plications including preterm birth and preeclampsia to
facilitate appropriate prioritisation of resources [4-6].
Table 5 Total costs of pregnancy to the NHS for all pregnant multiparous women and mean costs of pregnancy per pregnant multiparous women
(UK Sterling, price year 2010)
Group Average unit costs Best case scenario
(using lower quartile costs)
Worst case scenario
(using upper quartile costs)
Total costs of
pregnancy
Mean cost per
pregnant woman
Total costs of
pregnancy
Mean cost per
pregnant woman
Total costs of
pregnancy
Mean cost per
pregnant woman
Number % Number % Number %
1: Women with a previous healthy child £812,436,000 87.4 £2,147 £498,068,000 84.6 £1,316 £962,903,000 87.6 £2,544
2a: Women with a previous healthy child but has diabetes £80,470,000 8.7 £3,870 £65,128,000 11.1 £3,132 £92,229,000 8.4 £4,436
2b: Women with a previous healthy child but has hypertension £36,430,000 3.9 £2,920 £25,850,000 4.4 £2,072 £43,927,000 4.0 £3,521
Total £929,336,000 98.4 - £589,046,000 98.2 - £1,099,059,000 98.4 -
3a: Women with a previous stillbirth – known causes (non-recurrent) £2,719,000 18.0 £3,235 £1,902,000 17.8 £2,263 £3,309,000 18.0 £3,937
3b: Women with a previous stillbirth – known causes (recurrent) £9,420,000 62.2 £3,720 £6,660,000 61.9 £2,607 £11,410,000 62.2 £4,506
3c: Women with a previous stillbirth – unknown causes £2,371,000 15.7 £3,751 £1,664,000 15.6 £2,633 £2,872,000 15.7 £4,543
Total £14,510,000 1.5 - £10, 226,000 1.7 - £17,591,000 1.6 -
Overall Total £943,846,000 95.9 - £599,272,000 95.3 - £1,116,650,000 95.9 -
Group 3 refers to low risk multiparous women with a previous still birth. High risk women who have a previous still birth include those suffering from diabetes and hypertension and these account for 3.1% and 1% of
the population respectively of women who have a still birth and thus make up the remaining 4.1%. (i.e. 95.9% +4.1% = 100%).
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impact of stillbirth on costs and outcomes will facilitate
the evaluation of the cost-effectiveness of interventions
to prevent stillbirth in a realistic manner.
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